Literature DB >> 10956626

Hypoxia reduces atrial natriuretic peptide clearance receptor gene expression in ANP knockout mice.

J Z Sun1, S J Chen, G Li, Y F Chen.   

Abstract

We tested the hypotheses that hypoxic exposure is associated with exacerbated pulmonary hypertension and right ventricular (RV) enlargement, reduced atrial natriuretic peptide (ANP) clearance receptor (NPR-C) expression, and enhanced B-type natriuretic peptide (BNP) expression in the absence of ANP. Male wild-type [ANP(+/+)], heterozygous [ANP(+/-)], and homozygous [ANP(-/-)] mice were studied after a 5-wk hypoxic exposure (10% O(2)). Hypoxia increased RV ANP mRNA and plasma ANP levels only in ANP(+/+) and ANP(+/-) mice. Hypoxia-induced increases in RV pressure were significantly greater in ANP(-/-) than in ANP(+/+) or ANP(+/-) mice (104 +/- 17 vs. 45 +/- 10 and 63 +/- 7%, respectively) as were increases in RV mass (38 +/- 4 vs. 26 +/- 5 and 29 +/- 4%, respectively). NPR-C mRNA levels were greatly reduced in the kidney, lung, and brain by hypoxia in all three genotypes. RV BNP mRNA and lung and kidney cGMP levels were increased in hypoxic mice. These findings indicate that disrupted ANP expression worsens hypoxic pulmonary hypertension and RV enlargement but does not alter hypoxia-induced decreases in NPR-C and suggest that compensatory increases in BNP expression occur in the absence of ANP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10956626     DOI: 10.1152/ajplung.2000.279.3.L511

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  11 in total

1.  New insights and new hope for pulmonary arterial hypertension: natriuretic peptides clearance receptor as a novel therapeutic target for a complex disease.

Authors:  Emmanuel Eroume-A Egom; Tiam Feridooni; Rebabonye B Pharithi; Barkat Khan; Haaris A Shiwani; Vincent Maher; Yassine El Hiani; Robert A Rose; Kishore Bs Pasumarthi; Hilaire A Ribama
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-09-01

2.  Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide receptor (GC-A) deficient mice.

Authors:  M Kuhn; R Holtwick; H A Baba; J C Perriard; W Schmitz; E Ehler
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

3.  Effects of ozone and particulate matter on cardiac mechanics: role of the atrial natriuretic peptide gene.

Authors:  Clarke G Tankersley; Dimitrios Georgakopoulos; Wan-Yee Tang; Eric Abston; Alexis Bierman; Nicole Sborz
Journal:  Toxicol Sci       Date:  2012-09-13       Impact factor: 4.849

4.  Brain natriuretic peptide and acute hypobaric hypoxia in humans.

Authors:  David Woods; Tim Hooper; Adrian Mellor; Pete Hodkinson; Rob Wakeford; Bob Peaston; Steve Ball; Nic Green
Journal:  J Physiol Sci       Date:  2011-03-24       Impact factor: 2.781

5.  Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension.

Authors:  Eva Nozik-Grayck; Crystal Woods; Joann M Taylor; Richard K P Benninger; Richard D Johnson; Leah R Villegas; Kurt R Stenmark; David G Harrison; Susan M Majka; David Irwin; Kathryn N Farrow
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-17       Impact factor: 5.464

6.  Hypoxia increases the release of salmon cardiac peptide (sCP) from the heart of rainbow trout (Oncorhynchus mykiss) under constant mechanical load in vitro.

Authors:  Olli Arjamaa; Olli Vuolteenaho; Elina Kivi; Mikko Nikinmaa
Journal:  Fish Physiol Biochem       Date:  2013-06-29       Impact factor: 2.794

7.  Comparison of prognostic value of N-terminal pro-brain natriuretic peptide in septic and non-septic intensive care patients.

Authors:  Namik Ozcan; Ayse Ozcan; Cetin Kaymak; Hulya Basar; Mustafa Kotanoglu; Bektas Kose
Journal:  Arch Med Sci       Date:  2017-02-15       Impact factor: 3.318

Review 8.  Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction.

Authors:  Kailash N Pandey
Journal:  Int J Mol Sci       Date:  2019-08-14       Impact factor: 5.923

Review 9.  Cardiovascular Pleiotropic Effects of Natriuretic Peptides.

Authors:  Maurizio Forte; Michele Madonna; Sonia Schiavon; Valentina Valenti; Francesco Versaci; Giuseppe Biondi Zoccai; Giacomo Frati; Sebastiano Sciarretta
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

10.  Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent.

Authors:  Brian Casserly; James R Klinger
Journal:  Drug Des Devel Ther       Date:  2009-12-29       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.